SCHEMBL7513852

SCHEMBL7513852

C=CC(N)n1c(=O)c(C(=O)O)nc2ccccc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OGFRL1 Q5TC84 16/20 0.43
OPRM1 P35372 14/20 0.43
OPRK1 P41145 14/20 0.43
OPRD1 P41143 13/20 0.43
ALDH1A1 P00352 3/20 0.42
MAPT P10636 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CYP2C9 P11712 2/20 0.42
CYP2C19 P33261 2/20 0.42
MEN1 O00255 1/20 0.42
CYP3A4 P08684 1/20 0.42
HTT P42858 1/20 0.42
KMT2A Q03164 1/20 0.42
MAPK1 P28482 1/20 0.42
CASP1 P29466 1/20 0.42
CASP7 P55210 1/20 0.42
OPRL1 P41146 2/20 0.41
CYP1A2 P05177 1/20 0.41
GLA P06280 1/20 0.41
CYP2D6 P10635 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2831902 0.77 MAOA (0.51) ALDH1A1HTTMAPK1
SCHEMBL21366177 0.77 OGFRL1 (0.49) OGFRL1OPRM1OPRK1OPRD1ALDH1A1
SCHEMBL21366175 0.74 OGFRL1 (0.46) OGFRL1OPRM1OPRK1OPRD1ALDH1A1
SCHEMBL1969712 0.72 ALDH1A1 (0.45) ALDH1A1MAPTSMN1; SMN2CYP2C9CYP2C19
SCHEMBL28330812 0.71 MAPK1 (0.54) OGFRL1OPRM1OPRK1OPRD1ALDH1A1
SCHEMBL2783065 0.71 ALDH1A1 (0.59) OGFRL1OPRM1OPRK1OPRD1ALDH1A1
SCHEMBL29724622 0.71 ALDH1A1 (0.59) OGFRL1OPRM1OPRK1OPRD1ALDH1A1
SCHEMBL20206668 0.71 ALDH1A1 (0.53) OGFRL1OPRM1OPRK1OPRD1ALDH1A1
SCHEMBL19861061 0.71 OGFRL1 (0.53) OGFRL1OPRM1OPRK1OPRD1ALDH1A1
SCHEMBL11873127 0.70 HSD17B10 (0.65) ALDH1A1MAPTSMN1; SMN2CYP2C19MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1087768-A1 USE OF 1-(AMINOALKYL)-3-QUINOXALINE-2-ONE DERIVATIVES FOR THE PREPARATION OF COMPOUNDS HAVING AN ANTIOXIDANT ACTION PHAFAG AKTIENGESELLSCHAFT (LI) 2001-04-04 EP claimed
WO-1999066931-A1 USE OF 1-(AMINOALKYL)-3-QUINOXALINE-2-ONE DERIVATIVES FOR THE PREPARATION OF COMPOUNDS HAVING AN ANTIOXIDANT ACTION PHAFAG AKTIENGESELLSCHAFT (LI) 1999-12-29 WO claimed
EP-1087768-A1 USE OF 1-(AMINOALKYL)-3-QUINOXALINE-2-ONE DERIVATIVES FOR THE PREPARATION OF COMPOUNDS HAVING AN ANTIOXIDANT ACTION PHAFAG AKTIENGESELLSCHAFT (LI) 2001-04-04 EP disclosed
WO-1999066931-A1 USE OF 1-(AMINOALKYL)-3-QUINOXALINE-2-ONE DERIVATIVES FOR THE PREPARATION OF COMPOUNDS HAVING AN ANTIOXIDANT ACTION PHAFAG AKTIENGESELLSCHAFT (LI) 1999-12-29 WO disclosed